Chen Xiequn

[Expert Profile] Chen Xiequn, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in hematology in China, working in the Department of Hematology, Xijing Hospital, Air Force Medical University. He has long been dedicated to the clinical diagnosis, treatment, and scientific research of refractory platelet disorders and rare hematological diseases, and is an important expert in hematology in China.

[Education & Career] Professor Chen Xiequn graduated from the Fourth Military Medical University (now Air Force Medical University), completed systematic clinical training at Xijing Hospital, and further studied at famous international hematology centers. He has long served as Director of the Department of Hematology at Xijing Hospital, holding academic positions including member of the Hematology Branch of the Chinese Medical Association. He has presided over grants from the National Natural Science Foundation of China and key military research projects, and has accumulated profound academic achievements in the field of difficult hematological diseases.

[Areas of Expertise] Professor Chen specializes in the diagnosis and treatment of refractory platelet disorders such as immune thrombocytopenia (ITP), various rare hematological diseases, and difficult hematological conditions. He has extensive experience in comprehensive treatment of refractory thrombocytopenia, standardized application of novel drugs such as thrombopoietin receptor agonists (TPO-RA), and differential diagnosis of rare hematological diseases. He excels at managing difficult cases of "long-term low platelets with no response to multiple treatments," helping numerous platelet disorder patients raise platelet counts and reduce bleeding risk.

[Academic Achievements & Industry Contributions] Professor Chen has led a series of clinical studies on refractory platelet disorders and rare hematological diseases, systematically evaluating the efficacy and safety of different treatment strategies, with findings published in authoritative domestic and international journals. He has participated in the development of Chinese diagnostic standards for platelet disorders and rare hematological diseases, actively promoted the standardized application of novel platelet-raising drugs, and organized grassroots physician training and difficult case consultations, making important contributions to improving the care level of refractory platelet disorders and rare hematological diseases in China.

[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Chen has treated tens of thousands of patients with refractory platelet disorders and various hematological conditions, including many difficult patients who traveled across multiple regions seeking care. With noble medical ethics and exceptional technical skill, he has resolved the suffering of countless patients with "recurrent low platelets." He has received multiple military honors and awards, and is deeply trusted by patients and respected by peers alike. He is an important expert in hematology in both military and western Chinese healthcare systems.

[Honors & Reputation] Professor Chen Xiequn has long served as Director of the Department of Hematology at Xijing Hospital and Chair of the Hematology Branch of the Shaanxi Medical Association, among other academic positions. He has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and is an important discipline leader in hematology in northwestern China. He has accumulated extensive experience in the diagnosis and treatment of refractory platelet disorders and difficult rare hematological diseases. He has led the establishment of a multidisciplinary consultation system for difficult hematological diseases, promoted the standardized application of hematology genetic diagnosis and individualized treatment, and participated in the development of multiple hematology diagnosis and treatment guidelines. For decades on the clinical front lines, he has helped numerous difficult hematology patients receive clear diagnoses and standardized treatment, and is deeply trusted by patients and respected by peers alike.